Heart & Stroke Clinical Update
December 7-8, 2018
[Pre-Conference December 6, 2018]
Hilton Toronto Downtown Hotel
The Heart & Stroke Clinical Update will offer you practical pearls, scientific updates, and best practice discussions for the prevention and management of heart disease and stroke. All
programming is dedicated to the theme Emerging evidence that will change your practice.
Session Highlights
Workshop – My patient has had a TIA – Now what?
Presented by:
Cheryl Jaigobin, MD, MSc
Aline Bourgoin, RN, BScN, CNN(C)
Join this workshop covering the management of TIA and clinic referral. Learn how to appropriately identify TIA risk levels when triaging, differentiate between TIA & TIA mimics. Identify the underlying mechanisms of TIA and the required workup and management in an interdisciplinary setting. Understand the role and services of emergency departments and stroke prevention clinics, and resources for TIA & Minor strokes.
New evidence in stroke – Changing paradigms in care
Presented by:
Leanne Casaubon, MD, MSc, FRCPC
Michael D. Hill, MD, MSc, FRCPC
Mark Bayley, MD, FRCPC
Join the experts to harness the benefits of the explosion of stroke research and the updated guidelines – from acute stroke treatment, stroke prevention and rehabilitation. A plenary not to be missed.
Keynote Address – Patient engagement in healthcare and decision-making
Presented by:
Jennifer Price, RN, PhD
Expect an inspiring keynote address exploring a patient-centered approach to clinical decision-making; the benefits of patient engagement in research; and the integration of patient needs relating to gender, ethnicity, indigenous heritage, and geographical location.
Plenary – New evidence in heart disease – Reducing residual risk
Presented by:
John W. Eikelboom, MBBS, MSc, FRCPC
Ruth McPherson, MD, PhD, FRCPC, FACP, FRCS
Patrick R. Lawler, MD, MPH
This plenary will cover lipid optimization, making therapeutic decisions regarding combination therapy and targeting thrombosis and inflammation to reduce residual risk in patients with atherosclerotic cardiovascular disease.
